AP photo by Patricia McDonnell. Selling molecules is tricky - and companies only now are developing ways of conveying technical information about what's for sale without giving away secrets. Other intellectual property electronic exchanges are targeting the life sciences. Calif.-based Biostreet, operating since January, says it is already used by the top 20 pharmaceutical companies. A competitor, Newton-based ActiveCyte, has developed its own standard to display information about intellectual property.
Some analysts are skeptical.
By its nature, it's not tangible. There's just a lot of wasted energy in the matching process, just finding out who's got what, who's looking for what. The Knoxville News-Sentinel Co. All Rights Reserved.